Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molecularly guided therapy versus platinum chemotherapy in cancer of unknown primary after induction chemotherapy
NL-OMON55349Phase 2Recruiting
- Sponsor
- Roche
- Start
- Feb 2020
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in cancer of unknown primary (CUP) (2 arms), sponsored by Roche. Primary endpoint: Progression-free survival. Started Feb 2020; status: recruiting.
02
Conditions
cancer of unknown primary (CUP)
Beyond the preview
Go deeper on NL-OMON55349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55349.